Intra-Cellular Therapies (ITCI) – Hot FDA News
-
Intra-Cellular Therapies (ITCI) to Resume Trading at 7:30 a.m.
-
Intra-Cellular Therapies (ITCI) Announces U.S. FDA Approval of CAPLYTA for Treatment of Bipolar Depression in Adults
-
-
-
-
-
-
-
-
-
-
-
-
Back to ITCI Stock Lookup